A Bioelectronic Medicine Company

advancing the treatment of autoimmune diseases.

About Us

Boomerang Medical is a women-led bioelectronic medicine company on a mission to disrupt the treatment of autoimmune diseases. The company is developing a bioelectric neuromodulation technology, which has been granted Breakthrough Device Designation by the FDA for the treatment of Crohn's disease and ulcerative colitis. The technology is currently being evaluated in an FDA-approved clinical trial studying ulcerative colitis at leading IBD centers in the US.

Our Focus

Inflammatory Bowel Disease (IBD) is one of the most debilitating autoimmune diseases, affecting millions globally. Living with IBD impacts not just physical health, but also work, relationships, and well-being. Current treatments include medications and surgery, but the complexity of the condition means that there is always room for innovative approaches.

What if the next big leap in managing IBD is already hardwired into our bodies? That's the question propelling our focus on neuromodulation, a promising frontier in bioelectronic medicine.

Boomerang Medical is dedicated to promoting IBD awareness and education. We are proud to be a member of the Crohn’s & Colitis Foundation's Corporate Circle.

Boomerang Medical is headquartered in the heart of Silicon Valley on the campus of El Camino Hospital in Mountain View, California. We are proud to be a Company–In-Residence at the prestigious Fogarty Innovation incubator–the only healthcare-focused incubator of its kind in the US–giving us access to the brightest minds and expertise in the medical technology industry.

Does Inflammatory Bowel Disease disrupt your daily life?

Researchers in the BOOM-IBD2 Clinical Trial are exploring whether nerve stimulation, a therapy already approved by the FDA to treat other conditions, can be effective for treating Inflammatory Bowel Disease.

Join the trial

Meet the Team

Simonsen

President & Chief Executive Officer

Heather Simonsen

For 30 years, Heather has pursued her passion for solving the puzzle of bringing new medical technologies from bench to bedside. She is the former President of PQ Bypass, which was acquired in 2021 in one of the highest value vascular device transactions in recent history.

Co-Founder, Chief Innovation + Technology Officer

David Miller, MEng

David is an innovator and entrepreneur, holding more than 50 patents spanning diverse technologies and clinical applications. With over 20 years of experience, David has co-founded multiple companies, is a Stanford BioDesign Fellow, and was previously a Distinguished Scientist and Technical Fellow at Medtronic.

Vice President, Therapy Development

Lucas Payne

Lucas has 20+ years of experience leveraging his passion for patient care, HCP training and entrepreneurship to advance Class III medical device innovation for companies such as Johnson & Johnson and Abbott. Lucas began his career in the medical field in patient care as a radiation technologist.

Vice President, Clinical Affairs

Colleen Holthe

Colleen has a deep understanding of clinical research and regulatory affairs within the medical device industry. She holds 20+ years of experience conducting 25 clinical trials and a proven track record of leading Class III medical device trials from inception to FDA approval.

Senior Director, Clinical Therapy Development

Malea D'Amico, CCRA, CCRP

Malea has spent 21 years on the front lines of clinical research in over 70 medtech and biotech clinical trials. An expert in clinical study quality assurance, her experience crosses all phases clinical trials including benchwork, QA, monitoring, field support and patient outreach.

Director, Finance

Mariela Baughman

Mariela is a finance and accounting expert with over 30 years of experience working for startup medical technology companies. Previously, she was the Director of Finance and Human Resources at PQ Bypass.

Director, Clinical Data Management

BriAnna Maxam

BriAnna has spent almost 20 years working in many areas of clinical trials, having spent the last 14 years in the pre-market space working towards getting products successfully and efficiently through the FDA approval process. She's experienced in the design, build, and management of clinical trial data and databases, as well as in-depth analysis of trial outcomes and progress.

Director, Clinical Affairs

Stacey Miller

Stacey brings over two decades of experience in the medical device industry. Stacey's expertise lies in developing and executing global feasibility and pivotal studies for Class II and Class III devices. She has worked across a variety of therapeutic areas, including interventional cardiology, gastroenterology, and ENT.

Project Manager, Clinical + Regulatory Affairs

Grace Booth

Grace is a Regulatory expert with 22 years of experience in implantable medical devices. From Design Dossiers and Technical Files to breakthrough devices, her experience with FDA, notified bodies, and international agencies covers the full product lifecycle.